SAT-262-Long-term liver function outcome and related risk factors in HCV cirrhotic patients treated with direct-acting antiviral therapy: Results from the Navigatore platform in Veneto-Italy
Francesco Paolo Russo(University of Padua), A. Albertí(University of Padua), Franco Noventa(University of Padua), Giada Carolo, Veronica Paon, Valter Vincenzi, Patrizia Burra(University of Padua), Anna Maria Cattelan(University of Padua), Sara Piovesan, Sandro Panese, Liliana Chemello(University of Padua), I. Franceschet(University of Padua), Antonietta Romano(University of Padua), Martina Gambato(University of Padua), Caterina Pozzan, Paolo Angeli(University of Padua), S. Lobello, T. Bertin(Ospedale San Bortolo)
Cited by 0
Related Papers
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
|Journal of Hepatology|2018|2.8k
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k